Thursday, 17 April 2025
  
Login

Australia's most trusted
source of pharma news

Thursday, 17 April 2025
Ascott/Vivacity
Ascott/Vivacity
Trump tosses pharma 'a crumb'

US President Donald Trump is looking to eliminate the so-called 'pill penalty' in a win for industry but analysts are branding it a "bread crumb concession" ahead of tariffs.

Deal boosts pharma supply chain
Collaboration increases transparency and efficiency of supply chains for clinical trials in APAC
TODAY
Hidden blocks hold women back
Industry coach unpacks the mindset blocks standing in the way of success for women pharma leaders
TODAY
Lilly boss fires off PBS warning
Company could pull "tens of millions of dollars" invested in Aussie clinical trials unless the Fed Govt cuts time to reimbursement
16 April
Med Affairs boss jumps companies
Bringing 20 years experience in Aussie pharma to her new role heading a team which has almost doubled in size
16 April
J&J unveils two new offices
Bringing all of the company's businesses together in both Sydney and Melbourne for synergy and collaboration
15 April
Best CEO of 2025 runs a pharma
Chief Executive Magazine has named the latest CEO of the Year and it's someone who has led his pharma to astounding heights
15 April
Latest Jobs
Pharma in Focus  Jobs

Sales & Customer Relations (12)

Clinical & Medical, R&D (2)

Regulatory, Pharmacovigilance & QA (7)

Other (16)

Why pharma can't sit on the fence
Industry executive warns Aussie pharma can't risk "sitting out" trade debates arguing: if you are not engaged, you are exposed
TODAY
Drugs keeping Trump 'fighting fit'
US President undergoes his annual physical, revealing which drugs he takes to keep 'fully fit' as Commander-in-Chief
TODAY
Rare AE for new cancer drug
Australian researchers reveal rare side effect for promising blood cancer drug about to be considered by the PBAC
16 April
Organon launches IVF platform
Providing information and support on a complex process predicted to grow into a market worth more than $1 billion annually
16 April
TGA ticks booming drug
Just in time: new approval comes before the PBAC considers funding the indication at its meeting next month
16 April
PBAC takes a swing at sponsors
Puts the blame for "submission churn" at the feet of sponsors, claiming it's driven by deficits in information from companies
15 April
Customers pick fave pharmacy
Roy Morgan survey of 60,000 Aussies reveals which pharmacy ranks first in customer satisfaction... again
15 April
MA hires senior Health Dept exec
Joins industry body's Executive Team after being appointed to a newly created policy role at a critical time for pharma
15 April
$250K in fines for Code breaches
Two Australian pharmas have been hit with six-figure fines over two separate complaints of Code breaches
14 April
Who's the greenest Aussie pharma?
New research examines the progress towards sustainability of the largest pharmas in Australia
14 April
API bolsters access to PBS meds
New e-commerce platform elevates experience for 4,000-plus pharmacies, putting access to critical products at their fingertips
14 April
NZ brokers 'great deal' with AbbVie
Bundled deal with Pharmac will see new drugs funded to treat leukaemia as well as IBD plus another company wins a nod
14 April
Shake-up looms in MS market
Well-established MS treatment earning tens of millions now has a biosim rival latest drug registrations show
14 April Approvals Action
Local pharma slashes workforce
ASX-listed company once pegged to muscle in on lucrative eye market cuts two-thirds of employees
11 April
PiF advertise here
PiF advertise here
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.